Steward Partners Investment Advisory’s LeMaitre Vascular LMAT Stock Holding History

Steward Partners Investment Advisory’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55.2K	Sell	575 -650	-53%	-$66.6K	﹤0.01%	2892
2026 Q1	$134K	Sell	1,225 -4	-0.3%	-$381	﹤0.01%	2213
2025 Q4	$99.7K	Buy	1,229 +449	+58%	+$38.7K	﹤0.01%	2297
2025 Q3	$68.3K	Buy	780 +727	+1,372%	+$64.9K	﹤0.01%	2458
2025 Q2	$4.4K	Buy	53 +22	+71%	+$1.84K	﹤0.01%	3519
2025 Q1	$2.6K	Hold	31	–	–	﹤0.01%	3584
2024 Q4	$2.86K	Buy	+31	New	+$2.98K	﹤0.01%	3541
2022 Q3	–	Sell	-28	Closed	-$1K	–	3321
2022 Q2	$1K	Buy	+28	New	+$1.25K	﹤0.01%	3132
2021 Q2	–	Sell	-96	Closed	-$4.68K	–	7266
2021 Q1	$4.68K	Sell	96 -963	-91%	-$45.1K	﹤0.01%	3024
2020 Q4	$43K	Buy	1,059 +310	+41%	+$11.1K	﹤0.01%	1731
2020 Q3	$24K	Buy	+749	New	+$22.5K	﹤0.01%	1826
2018 Q1	–	Sell	-21	Closed	–	–	2275
2017 Q4	$0	Buy	+21	New	+$719	﹤0.01%	1915

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Steward Partners Investment Advisory's LMAT Position: Q2 2026 in Review

Steward Partners Investment Advisory reduced its LeMaitre Vascular (LMAT) stake by 53% in Q2 2026, selling an estimated $66.6K and leaving 575 shares worth $55.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2892.

Steward Partners Investment Advisory first reported a position in LMAT in Q4 2017 and has held it in 12 quarters since. The position peaked at $134K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Steward Partners Investment Advisory held 575 shares of LeMaitre Vascular worth $55.2K as of Q2 2026.
Steward Partners Investment Advisory sold 650 LeMaitre Vascular shares in Q2 2026, an estimated $66.6K.
LeMaitre Vascular made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2892 holding.
Steward Partners Investment Advisory first reported a position in LeMaitre Vascular in Q4 2017 and has held it in 12 quarters since.
Steward Partners Investment Advisory's LeMaitre Vascular position peaked at $134K in Q1 2026.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.